Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...
Conventional TIL therapy, clinically validatedrecently with the U.S. Food and Drug Administration approval of lifileucel for advanced melanoma,stillfaces substantial hurdles.